142 related articles for article (PubMed ID: 23913151)
1. Conjugation process development and scale-up.
Stump B; Steinmann J
Methods Mol Biol; 2013; 1045():235-48. PubMed ID: 23913151
[TBL] [Abstract][Full Text] [Related]
2. Current methods for the synthesis of homogeneous antibody-drug conjugates.
Sochaj AM; Ĺwiderska KW; Otlewski J
Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the development and manufacturing of antibody-drug conjugates.
Ducry L
Methods Mol Biol; 2012; 899():489-97. PubMed ID: 22735971
[TBL] [Abstract][Full Text] [Related]
4. Current Status: Site-Specific Antibody Drug Conjugates.
Schumacher D; Hackenberger CP; Leonhardt H; Helma J
J Clin Immunol; 2016 May; 36 Suppl 1():100-7. PubMed ID: 27003914
[TBL] [Abstract][Full Text] [Related]
5. Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics.
Kaur S; Xu K; Saad OM; Dere RC; Carrasco-Triguero M
Bioanalysis; 2013 Jan; 5(2):201-26. PubMed ID: 23330562
[TBL] [Abstract][Full Text] [Related]
6. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.
Zimmerman ES; Heibeck TH; Gill A; Li X; Murray CJ; Madlansacay MR; Tran C; Uter NT; Yin G; Rivers PJ; Yam AY; Wang WD; Steiner AR; Bajad SU; Penta K; Yang W; Hallam TJ; Thanos CD; Sato AK
Bioconjug Chem; 2014 Feb; 25(2):351-61. PubMed ID: 24437342
[TBL] [Abstract][Full Text] [Related]
7. Challenges in developing bioanalytical assays for characterization of antibody-drug conjugates.
Stephan JP; Kozak KR; Wong WL
Bioanalysis; 2011 Mar; 3(6):677-700. PubMed ID: 21417735
[TBL] [Abstract][Full Text] [Related]
8. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry.
Valliere-Douglass JF; Hengel SM; Pan LY
Mol Pharm; 2015 Jun; 12(6):1774-83. PubMed ID: 25474122
[TBL] [Abstract][Full Text] [Related]
9. Current approaches for the purification of antibody-drug conjugates.
Matsuda Y
J Sep Sci; 2022 Jan; 45(1):27-37. PubMed ID: 34473399
[TBL] [Abstract][Full Text] [Related]
10. Challenges and new frontiers in analytical characterization of antibody-drug conjugates.
Wagh A; Song H; Zeng M; Tao L; Das TK
MAbs; 2018; 10(2):222-243. PubMed ID: 29293399
[TBL] [Abstract][Full Text] [Related]
11. Designing immunoconjugates for cancer therapy.
Govindan SV; Goldenberg DM
Expert Opin Biol Ther; 2012 Jul; 12(7):873-90. PubMed ID: 22679911
[TBL] [Abstract][Full Text] [Related]
12. An overview of process development for antibody-drug conjugates produced by chemical conjugation technology.
Matsuda Y; Mendelsohn BA
Expert Opin Biol Ther; 2021 Jul; 21(7):963-975. PubMed ID: 33141625
[No Abstract] [Full Text] [Related]
13. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
Agarwal P; Bertozzi CR
Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
[TBL] [Abstract][Full Text] [Related]
14. Linker technologies for antibody-drug conjugates.
Nolting B
Methods Mol Biol; 2013; 1045():71-100. PubMed ID: 23913142
[TBL] [Abstract][Full Text] [Related]
15. Analytical and bioanalytical technologies for characterizing antibody-drug conjugates.
Alley SC; Anderson KE
Curr Opin Chem Biol; 2013 Jun; 17(3):406-11. PubMed ID: 23570980
[TBL] [Abstract][Full Text] [Related]
16. Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy.
Li M; Zhao X; Yu C; Wang L
Pharm Res; 2024 Mar; 41(3):419-440. PubMed ID: 38366236
[TBL] [Abstract][Full Text] [Related]
17. A new large-scale manufacturing platform for complex biopharmaceuticals.
Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
[TBL] [Abstract][Full Text] [Related]
18. Analytical Comparison of Antibody-drug Conjugates Based on Good Manufacturing Practice Strategies.
Tawfiq Z; Matsuda Y; Alfonso MJ; Clancy C; Robles V; Leung M; Mendelsohn BA
Anal Sci; 2020 Jul; 36(7):871-875. PubMed ID: 32336726
[TBL] [Abstract][Full Text] [Related]
19. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
[TBL] [Abstract][Full Text] [Related]
20. [Antibody-drug conjugates and their application in the treatment of hematological malignancies].
Lin L; Ding Q; Tang Q; Zhang ZZ; Dai Z; Zhan JB
Yao Xue Xue Bao; 2012 Oct; 47(10):1287-96. PubMed ID: 23289140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
